Quantcast
Channel: ClinicalTrials.gov: peregrine pharmaceuticals | Last update posted in the last 30 days
Viewing all articles
Browse latest Browse all 55

Bavituximab With Radiation and Temozolomide for Patients With Newly Diagnosed Glioblastoma

$
0
0
Condition:   Glioblastoma
Interventions:   Drug: Temozolomide;   Drug: Bavituximab;   Radiation: Radiation
Sponsors:   Massachusetts General Hospital;   Peregrine Pharmaceuticals;   National Comprehensive Cancer Network
Active, not recruiting

Viewing all articles
Browse latest Browse all 55

Latest Images

Trending Articles





Latest Images